Drug
A Jnj 39758979 Placebo 1
A Jnj 39758979 Placebo 1: highest development phase Phase 1, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| A:JNJ-39758979/Placebo #1 NCT01068223 | Phase 1 | Histamine Induced Itch |
Latest
No recent events.
Follow A Jnj 39758979 Placebo 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.